Epidemiology of HIV-associated cryptococcosis in France (1985-2001):: comparison of the pre- and post-HAART eras

被引:137
作者
Dromer, F [1 ]
Mathoulin-Pélissier, S
Fontanet, A
Ronin, O
Dupont, B
Lortholary, O
机构
[1] Inst Pasteur, Unite Mycol Mol, Ctr Natl Reference Mycol & Antifongiques, F-75724 Paris, France
[2] Inst Bergonie, Serv Biostat, Bordeaux, France
[3] Inst Pasteur, Unite Epidemiol Malades Emergentes, F-75724 Paris, France
[4] Hop Necker Enfants Malad, Serv Malades Infectieuses & Trop, Paris, France
关键词
cryptococcosis; epidemiology; HAART; Cryptococcus neoformans; HIV; AIDS;
D O I
10.1097/00002030-200402200-00024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To analyse the epidemiological evolution of cryptococcosis in France after the introduction of highly active antiretroviral therapy (HAART). Design: Retrospective study of cryptococcosis cases recorded at the National Reference Center for Mycoses in France since 1985. Methods: Using the national surveillance data, we reviewed 1644 cases of HIV-associated cryptococcosis diagnosed in France (population, 59 million) between 1985 and 2001 and compared them to 335 cases recorded in HIV-negative patients. Results: The total number of cryptococcosis cases evolved in parallel to that recorded for HIV-infected patients. Changes occurring after HAART introduction were analysed. A negative binomial regression model established a 46% decrease of the incidence of cryptococcosis during the post-HAART era (1997-2001, n = 292) compared to the pre-HAART era (1985-1996, n = 1352). According to multivariate analysis, African origin, older age, heterosexual HIV contamination, no previous AIDS-defining illness, and no previous HIV infection diagnosis were variables independently associated with an increased risk of cryptococcosis during the post-HAART era. During the same period, the characteristics of the HIV-negative population did not change. Conclusions: Our analysis of the national surveillance identified demographic factors associated with an increased risk of cryptococcosis in the post-HAART era suggesting that failure to consult and considering oneself not at risk were determinant in the current epidemiology of HIV-related cryptococcosis in France. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:555 / 562
页数:8
相关论文
共 41 条
[1]   EXPANDED EUROPEAN AIDS CASE DEFINITION [J].
ANCELLEPARK, R .
LANCET, 1993, 341 (8842) :441-441
[2]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[3]   Cryptococcus neoformans infection in a cohort of Italian AIDS patients:: Natural history, early prognostic parameters, and autopsy findings [J].
Antinori, S ;
Galimberti, L ;
Magni, C ;
Casella, A ;
Vago, L ;
Mainini, F ;
Piazza, M ;
Nebuloni, M ;
Fasan, M ;
Bonaccorso, C ;
Vigevani, GM ;
Cargnel, A ;
Moroni, M ;
Ridolfo, A .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (10) :711-717
[4]   INCIDENCE OF CLINICAL AIDS CONDITIONS IN A COHORT OF HOMOSEXUAL MEN WITH CD4(+) CELL COUNTS LESS-THAN-100/MM(3) [J].
BACELLAR, H ;
MUNOZ, A ;
HOOVER, DR ;
PHAIR, JP ;
BESLEY, DR ;
KINGSLEY, LA ;
VERMUND, SH .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05) :1284-1287
[5]   Rare AIDS-defining diseases in the Swiss HIV Cohort Study [J].
Burckhardt, B ;
Sendi, P ;
Pfluger, D ;
Zimmerli, W ;
Nüesch, R ;
Bucher, HC ;
Drewe, J ;
Gyr, N ;
Battegay, M .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (06) :399-402
[6]  
*CDCP, 2002, MMWR-MORBID MORTAL W, V51, P592
[7]   Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand [J].
Chen, S ;
Sorrell, T ;
Nimmo, G ;
Speed, B ;
Currie, B ;
Ellis, D ;
Marriott, D ;
Pfeiffer, T ;
Parr, D ;
Byth, K .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) :499-508
[8]   Cryptococcosis in Australasia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B [J].
Chen, SCA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 :57-61
[9]   Morbidity and mortality in South African gold miners: Impact of untreated disease due to human immunodeficiency virus [J].
Corbett, EL ;
Churchyard, GJ ;
Charalambos, S ;
Samb, B ;
Moloi, V ;
Clayton, TC ;
Grant, AD ;
Murray, J ;
Hayes, RJ ;
De Cock, KM .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (09) :1251-1258
[10]   ESTIMATION OF THE PREVALENCE OF CRYPTOCOCCAL INFECTION AMONG PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS IN NEW-YORK-CITY [J].
CURRIE, BP ;
CASADEVALL, A .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (06) :1029-1033